Kephera Diagnostics, LLC is a start-up focused on development of point-of-care assays for a variety of disease conditions. Areas of focus include emerging pathogens that are of high global public health significance. We work with research partners in academic and government laboratories in the U.S. and internationally to translate basic science into effective diagnostic products that address under-served medical needs. To meet this challenge, we are developing new and innovative assay technologies. Kephera also operates a CAP-accredited, CLIA-certified clinical laboratory, offering diagnostic testing services for Chagas Disease, Liver Fluke infection, Neurocysticercosis, and Lyme Disease.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 1 Grant St, Framingham,massachusetts 01702,united States
- in****@****era.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- kepheradx.com
- Keywords
- Diagnostics.
- HQ
- Framingham, Massachusetts
Kephera Diagnostics Questions
Kephera Diagnostics's website is kepheradx.com
Kephera Diagnostics's LinkedIn profile is https://www.linkedin.com/company/kephera-diagnostics
Kephera Diagnostics has
14 employees.
View email and phone details for 14
employees at Kephera Diagnostics.
Kephera Diagnostics's industry is
Biotechnology Research
Kephera Diagnostics's top competitors are
Bioporto Diagnostics A/s,
Proof Diagnostics, Inc.,
Genabio Diagnostics,
Scientia Diagnostics,
Altona Diagnostics,
Brightview,
Oxford Nanopore Technologies,
Exosome Diagnostics, A Bio-Techne Brand,
Selux Diagnostics, Inc,
Sherlock Biosciences.
Kephera Diagnostics's support email address is info@kephera.com
Kephera Diagnostics's categories are Biotechnology Research
Kephera Diagnostics's founding year is 2017
